Alkem Laboratories Q2 Results

  • BSE: 539523
  • NSE: ALKEM
  • ISIN: INE540L01014
  • Sector: Biotechnology & Drugs
BSE
5,399.00-19.75 (-0.36%)
Volume17.23 K
Updated: Fri 14 Aug, 2026 | 15:29:35
NSE
5,368.00-81.50 (-1.50%)
Volume6.36 L
Updated: Fri 14 Aug, 2026 | 15:50:30
Today: 5,173.50
5,554.90
52-Wk: 4,740.65
5,933.00

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Alkem Laboratories Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 26QoQ CompSep 24YoY Comp
    Total Operating Expense 3,173.833,074.2917.25%2,740.7515.80%
    Depreciation/ Amortization 93.61100.196.76%78.9118.63%
    Operating Income 827.16665.8624.52%673.9222.74%
    Net Income 765.06519.9615.17%688.6411.10%
    Other Operating Expenses Total 968.94963.9326.22%846.6514.44%
    Net Income Before Taxes 895.34771.4816.19%780.2614.75%
    Total Revenue 4,000.993,740.1518.68%3,414.6717.17%
    Selling/ General/ Admin Expenses Total 710.25808.902.45%610.4916.34%
    Diluted Normalized EPS 63.9943.4917.15%57.6011.09%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market